Alfuraih Saleh, Tran Amy, Kim Lois, Ansari Rais, Sharma Ajay
Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Chapman University, Irvine, CA, United States.
Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Health Professions Division, Nova Southeastern University, Fort Lauderdale, FL, United States.
Front Immunol. 2024 Dec 19;15:1505508. doi: 10.3389/fimmu.2024.1505508. eCollection 2024.
Due to its location, the ocular surface is exposed to environmental microbes. Innate immune cells including macrophages are first line defense against infections. exposure to high glucose as well as diabetes-associated hyperglycemia has been shown to affect innate immune cell function and population. The present study was designed to examine the effect of diabetes-associated hyperglycemia on the lacrimal gland, conjunctiva and cornea macrophage population, phenotypic changes and cytokines/chemokines.
Mouse model of Streptozotocin-induced diabetes was used to induce hyperglycemia. Immunostaining for CD11b and F4/80 was performed to stain macrophages in whole mount cornea, conjunctiva and 50 µm lacrimal gland sections. Flowcytometry was performed on single cell suspension to identify macrophage phenotypes and activation using CD11b, F4/80, CD80, CD206 and MHCII staining. Real time PCR was performed to quantify gene expression for macrophage-associated cytokines (IL-1β, TNF-α, IFN-γ) and chemokine (CCL2).
Our data demonstrates the diabetes-associated hyperglycemia caused a rapid onset and significant decrease in macrophage population in lacrimal gland, conjunctiva and cornea. The onset of this noted decrease was as early as 7 days after hyperglycemia in lacrimal gland and conjunctiva followed by a notable increase towards recovery only in conjunctiva but not in the lacrimal gland. The cornea tissue showed a steady decline up to the tested time point of 28 days. Further, hyperglycemia did not cause any notable changes in macrophage phenotypes, their activation status or the expression of IL-1β, TNF-α, IFN-γ, CCL2 except in the cornea where an increase in the cytokine levels was noted after 7 days of hyperglycemia.
Our data shows that diabetes-associated hyperglycemia can cause a significant decrease in microphage population with changing their plasticity or activation status in lacrimal gland, conjunctiva and cornea but the kinetics of decrease and recovery show differential pattern specific for each tissue.
由于其位置,眼表暴露于环境微生物中。包括巨噬细胞在内的先天免疫细胞是抵御感染的第一道防线。已表明暴露于高血糖以及与糖尿病相关的高血糖会影响先天免疫细胞功能和数量。本研究旨在检查与糖尿病相关的高血糖对泪腺、结膜和角膜巨噬细胞数量、表型变化以及细胞因子/趋化因子的影响。
使用链脲佐菌素诱导的糖尿病小鼠模型诱导高血糖。对全层角膜、结膜和50微米泪腺切片进行CD11b和F4/80免疫染色以标记巨噬细胞。对单细胞悬液进行流式细胞术,使用CD11b、F4/80、CD80、CD206和MHCII染色来鉴定巨噬细胞表型和活化情况。进行实时PCR以定量巨噬细胞相关细胞因子(IL-1β、TNF-α、IFN-γ)和趋化因子(CCL2)的基因表达。
我们的数据表明,与糖尿病相关的高血糖导致泪腺、结膜和角膜中巨噬细胞数量迅速减少且显著下降。这种明显减少最早在高血糖7天后出现在泪腺和结膜中,随后仅结膜中出现明显增加并趋向恢复,而泪腺中未恢复。角膜组织在长达28天的测试时间点显示出稳定下降。此外,高血糖除了在角膜中高血糖7天后细胞因子水平升高外,未引起巨噬细胞表型、其活化状态或IL-1β、TNF-α、IFN-γ、CCL2表达的任何显著变化。
我们的数据表明,与糖尿病相关的高血糖可导致泪腺、结膜和角膜中巨噬细胞数量显著减少,且不改变其可塑性或活化状态,但减少和恢复的动力学显示出各组织特有的差异模式。